SoloPace announces US FDA clearance and first-in-human use of TAVI temporary pacing system
SoloPace Incorporated has announced both US Food and Drug Administration (FDA) clearance and first-in-human use of its SoloPace control system for temporary pacing in...
Stereotaxis features first-ever live demonstration of GenesisX robotic system at HRS 2025
Stereotaxis announced recently that it hosted a demonstration of the GenesisX robotic system at this year’s Heart Rhythm Society (HRS) meeting (24–27 April, San...
US FDA approves “world’s first and only” leadless LVEP device for cardiac resynchronisation therapy
EBR Systems has received US Food and Drug Administration (FDA) approval of the WiSE system—marking what the company describes as a significant leap forward...
US Heart Rhythm Society announces new framework to establish AF centres of excellence and...
The US Heart Rhythm Society (HRS) has released a framework outlining criteria for establishing an atrial fibrillation (AF) centre of excellence (CoE) and key...
